Green Cross Valuation
| 142280 Stock | KRW 3,725 35.00 0.93% |
At this time, the firm appears to be fairly valued. Green Cross Medical retains a regular Real Value of W3618.96 per share. The prevalent price of the firm is W3725.0. Our model calculates the value of Green Cross Medical from evaluating the firm fundamentals such as Return On Equity of -42.94, current valuation of 272.85 B, and Return On Asset of 0.0313 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Green Cross' price fluctuation is very steady at this time. Calculation of the real value of Green Cross Medical is based on 3 months time horizon. Increasing Green Cross' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Green Cross is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Green Stock. However, Green Cross' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3725.0 | Real 3618.96 | Hype 3760.0 | Naive 3665.57 |
The real value of Green Stock, also known as its intrinsic value, is the underlying worth of Green Cross Medical Company, which is reflected in its stock price. It is based on Green Cross' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Green Cross' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Green Cross Medical helps investors to forecast how Green stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Green Cross more accurately as focusing exclusively on Green Cross' fundamentals will not take into account other important factors: Green Cross Total Value Analysis
Green Cross Medical is presently forecasted to have takeover price of 272.85 B with market capitalization of 51.07 B, debt of 6.16 B, and cash on hands of 1.84 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Green Cross fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
272.85 B | 51.07 B | 6.16 B | 1.84 B |
Green Cross Investor Information
About 55.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Green Cross Medical had 2683:2206 split on the 30th of September 2019. Based on the key indicators related to Green Cross' liquidity, profitability, solvency, and operating efficiency, Green Cross Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Green Cross Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Green Cross has an asset utilization ratio of 106.32 percent. This suggests that the Company is making W1.06 for each dollar of assets. An increasing asset utilization means that Green Cross Medical is more efficient with each dollar of assets it utilizes for everyday operations.Green Cross Ownership Allocation
The market capitalization of Green Cross is W51.07 Billion. Green Cross secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Green Cross Profitability Analysis
The company reported the revenue of 101.67 B. Net Loss for the year was (21.14 B) with profit before overhead, payroll, taxes, and interest of 19.78 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Green Cross' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Green Cross and how it compares across the competition.
About Green Cross Valuation
The stock valuation mechanism determines Green Cross' current worth on a weekly basis. Our valuation model uses a comparative analysis of Green Cross. We calculate exposure to Green Cross's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Green Cross's related companies.GreenCross Medical Science Corp. manufactures and sells diagnostic reagents in South Korea. The company was founded in 2003 and is headquartered in Yongin, South Korea. GCMS is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Green Cross' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Green Cross' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Green Cross' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Green Cross' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Green Cross' revenue streams: Identify Green Cross' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Green Cross' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Green Cross' growth potential: Evaluate Green Cross' management, business model, and growth potential.
- Determine Green Cross' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Green Cross' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Green Stock analysis
When running Green Cross' price analysis, check to measure Green Cross' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cross is operating at the current time. Most of Green Cross' value examination focuses on studying past and present price action to predict the probability of Green Cross' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cross' price. Additionally, you may evaluate how the addition of Green Cross to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |